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Abstract. This study has in view to establish and test the sensitivity of Staphylococcus aureus antibiotics. There are different
injuries caused by superficial skin infections: from simple pimples to infections that endanger our lives, like an abscess, furuncle
septicemia, meningitis, toxic food, urinary tract infection at sexually active young women. Samples have been taken from 30 people
with staphylococcus infections. They were nineteen women and eleven men, between the age of 2 and 79. During this study some
antibiograms have been made, based on pharyngeal exudates, acne secretion and urine culture. It has been established that the most
efficient recommended antibiotics are: oxacilin, erythromycin, rifampicin and ciprofloxacin. The penicillin turned out to be less
efficient to remove and destroy the Staphylococcus aureus species.
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INTRODUCTION
This study had in view to establish and test the
sensitivity of Staphylococcus aureus bacteria, because
of its multiple effect on skin, nasal lining, pharynx and
the urine culture.
Staphylococcus can cause a wide range of
infections. Their severity and location vary from
superficial skin infections, to infections which
endanger our lives like septicemia and meningitis.
Mostly, the Staphylococcus produces penicillinaze.
Some people can even resist without any kind of
problems to analogues of penicillin.
The three most common types of Staphylococcus
are: Staphylococcus aureus, Staphylococcus
epidermidis (resistance of the nasal vestibule and
teguments, accidental pathogen, found in subacute
bacterial endocarditis, followed by surgery and
cardiovascular explorations at the level of the infected
acne) and Staphylococcus saprophyticus (external
environment saprophyte may contaminate the lining
and teguments).
Staphylococcus aureus is a bacteria widely spread
in the environment, like in air, dust and on the
household  items.  Healthy  people  have  it,  in  a
percentage of 30% on their nasal lining. The
percentage is even higher at people, who work in the
hospital, at patients who need dialysis, those who have
diabetes and those who use intravenous drugs.
Staphylococcus aureus is also a pathogen species
and presents superficial skin infections from simple
pimples to infections that endanger our lives, like an
abscess, furuncle septicemia, meningitis, toxic food,
urinary tract infection at sexually active young women.
It can cause different angina, a bronchitis and lung
infection which, in case of children, forms
bronchopneumonia and is often fatale [1].
Staphylococcus aureus can be treated with a wide
range of antibiotics. Efficient and inefficient antibiotics
were enlisted. In specialized literature, we identified 10
groups of antibiotics: penicillin, oxacilin, gentamicin,
tobromicin, tetracycline, erythromycin, clindamycin,
vancomycin, rifampicin, linezolid and ciprofloxacin.
Taking  into  consideration  the  last  years,  branches  of
Staphylococcus aureus and Staphylococcus
epidermidis have been developed. These are resistant
to methicillin, to all kind of penicillin, to almost every
cephalosporin, to streptomycin and tetracycline.
Penicillin, represented by ampicillin and amoxicillin, is
an efficient antibiotic from this species.
Oxacillin can be used as a mono therapy in the
treatment of staphylococcus infections. Oxacilin might
be useful in case of dangerous staphylococcus
infections, endocarditis and septicemia in association
with active aminoglycoside. Gentamicin and
tobromicin have a large antimicrobial spectrum. The
tetracycline is formed of Gram positive and Gram
negative, aerobe and anaerobe bacteria. Brand new and
resistant branches were selected. This is the reason why
they are rarely used as antibiotics. Gram positive
coccus are inhibited by small concentrations. The MIC
for Staphylococcus, Streptococcus and Pneumococcus
is 0.2 and 3.1 mcg/ml [18].
Patients who are allergic to penicillin can use
eritromycin. These patients have slight infections of
staphylococcus, streptococcus, pneumococcus, anthrax
and syphilis. Recently, it has been discovered that the
eritromicin can be used with success in vulgar acne
therapy [18].
Clindamycin is useful in sever staphylococcus
infections, like in case of staphylococcus infections
resistant to G penicillin, but sensitive to clindamycin.
Several branches of Staphylococcus aureus are
inhibited at a concentration of 0.4 mcg/ml [7].
Vancomycin and teicoplanina have a major effect
on staphylococcus infections resistant to methicillin.
Linesolid is used in Staphylococcus infections
(resistant to methicillin), pneumonia (caused by
Staphylococcus aureus), communitary pneumonia, skin
infections, soft tissue infections and bacterial
endocarditis with sensitive germs [7].
Staphylococcus has a great sensitivity. For
Staphylococcus aureus the MIC is 0.005-0.001
mcg/ml. The antibiotic is active also in the case of poliAnalele UniversităĠii din Oradea, Fascicula Biologie                                                                                                                                              Tom. XVI / 2, 2009, pp. 70-73
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resistant branches - Staphylococcus resistant to G
penicillin and methicillin and/or vancomycin. It may
have a synergistic reaction, when the penicillin is
resistant to penicillinaze and vancomycin [18].
Ciprofloxacin presents a high efficiency against
bacteria resistant to aminoglycoside, penicillin,
cephalosporine, tetracycline and other antibiotics.
Infections of the middle ear (middle otitis) and
paranasal sinuses (sinusitis) may appear, especially if
these are generated by Pseudomonas and
Staphylococcus [18].
The efficacy of chlorhexidine digluconate was
determined against some strains of collected and
clinically isolated bacteria and fungi. The efficacy was
evaluated either by calculating a minimum inhibitory
concentration (MIC). The MIC values of chlorhexidine
for Staphylococcus aureus, Microsporum gypseum,
Microsporum canis and Trichophyton mentagrophytes
were 0.625 ȝg/ml, 12.5 ȝg/ml, 50 ȝg/ml and 6.25
ȝg/ml, respectively. The in vitro efficacy of
chlorhexidine was higher against the strains of
Staphylococcus aureus and Pseudomonas aeruginosa
(0.5 mg/ml for 5 min and 0.5 mg/ml for 10 min) than
against clinical isolates [15].
It is generally accepted that methicillin-resistant
Staphylococcus aureus is also resistant to
aminoglycoside antibiotics. We investigated trends of
gentamicin and arbekacin susceptibilities and the
prevalence of the genes encoding aminoglycoside-
modifying enzymes (AMEs) for a total of 218 strains
of MRSA isolated from blood specimens obtained from
1978 through 2002 in one hospital. The minimum
inhibitory concentrations of gentamicin at which 50%
of the strains that were inhibited (MIC50) are 0.5 μg/ml
for the isolates obtained from 1990 to 2002. The MIC90
of gentamicin was consistently 128 μg/ml. Our results
imply that gentamicinresistant and arbekacin-resistant
MRSA’s have consistently decreased for the past 25
years [3].
MATERIALS AND METHODS
Thirty persons with staphylococcus infections have
been studied, 19 women and 11 men, between the age
of 2 and 79. Patients have been examined. Nasal and
pharinx secretion, acne secretion and urine culture has
been collected. It’s compulsory to establish the
sensitivity of antibiotics and chemotherapy of every
bacterial branch in order to determine the right
treatment.
Usually, a branch can be considered sensitive if the
germs are efficiently affected by the antibiotic. The
therapeutic effect may be obtained with the help of
“usual” doses and administration. The branch may be
considered slightly sensitive if the germs are little
affected. The therapeutic effect cannot be obtained but
in special conditions (like, to recommend a higher
doses  than  as  usual,  the  use  of  some  special
administration: intravenous injection and intrarahidiane
injection) [16].
Bacteria sensitivity towards antibiotics is tested “in
vitro”, assuring them standard culture condition
(culture environment, inocul and incubation time) in
the presence of a smaller quantity of antibiotic.
Basically, a branch is resistant if the result of the
sensitivity tested ”in vitro” is negative.
The antibiogram can be made by a test “in vitro.” It
represents the lab method, showing the antibiotic
sensitivity of germs, collected from patients with
bacterial infections. These are cultivated in special
environments (for instance on the Mueller-Hinton
agar). We have to use pure cultures for antibiograms (a
single bacterial branch), even in case of multibacterial
infections.
The isolation of Stafilococcus aureus is based on its
growth in a simple environment and in a
hyperchorinate environment. On the agarose, the blood
is developed in colonies of 2-3 mm. The colonies have
a creamy consistence. Usually, it contains ȕ-hemolysis
[19].
We submitted a disk with antibiotics, on the surface
of a solid environment, planted with a bacterial culture.
The active antimicrobial substance will run into the
environment, having a small concentration, started
from the edge of the microtablet.
After a certain time of incubation, there are two
different ways to follow: the first one, because here the
microbial growth is inhibited by a concentration of
antimicrobial substance. Second, a growing area, where
the antibiotic concentration is too small for a growing
inhibition.
If the diameter of the inhibitive area is bigger, the
germ is more sensitive. The quantity of the antibiotic
necessary to the inhibition of the tested bacteria
(minimum inhibited concentration=MIC), is smaller.
There is an inversely proportional relation between the
diameter of the inhibited area and MIC [10, 11].
RESULTS
Staphylococcus frequently produces infections
which can be treated only in hospital. This is the reason
why it is recommended to test their sensitivity to
antibiotics for a right treatment.
In this order, there are: pharynx and nasal perspire,
acne secretion and urine culture. Than, the so - called
antibiograms. As concerning the pharynx perspire, a
group of 10 people were tested: 4 men and 6 women
with ages between 20 and 49. This test was made on 7
children (4 girls and 3 boys) between the ages of 2 and
14.
The nasal perspires has been made on a group of 10
people (4 men and 6 women), between the age of 18
a n d 5 2 . O n l y o n e n a s a l p e r s p i r e h a s b e e n m a d e o n
children. In order to test the resistance of
Staphylococcus aureus on antibiotics, the acne
secretion has been made on a single woman (aged
25).The urine culture, has been made on a single
woman, too (aged 79).
In the case of antibiograms, the following
antibiotics have been used: penicillin, oxacilin,
gentamicin, tobromicin, tetracycline, erythromycin,
clindamycin, vancomycin, rifampicin, linezolid and
ciprofloxacin.
The concentration / microtablets of the antibiotics
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(based on the above mentioned method), and after the
inhibition was established, meaning the minimum
inhibitive concentration (MIC), the obtained results
were statistically processed, permitting to achieve the
following figure.
Using the statistical tests, we established 4 most
efficient antibiotics: oxacilin, erythromycin, rifampicin
and ciprofloxacin. These antibiotics may be
recommended and used in different kind of disease
caused by Staphylococcus aureus (Fig. 1). Different
kind of disease caused by Staphylococcus aureus may
be treated and used with other antibiotics, like the
linezolid (Fig. 2).
As concerning the tested antibiotics, we established
that penicillin is less efficient (63.33% cases) in order
to treat Staphylococcus aureus (Fig. 3.).
76,66%
3,33%
13,33%
6,66%
oxacilin erythromycin rifampicin ciprofloxacin
Figure 1. The most efficient antibiotic used in the case of
Staphylococcus aureus.
13,33%
23,33%
26,66%
13,33%
6,66%
16,66%
linezolid rifampicin ciprofloxacin erythromycina oxacilin others
Figure 2. Other antibiotics which can be used in the case of
Staphylococcus aureus.
63,33%
13,33%
6,66% 3,33% 3,33% 6,66%
penicillin tobramicin erythromycin
ciprofloxacin linezolid tetracycline
Figure 3. Inefficient antibiotics in the case of Staphylococcus
aureus.
Depending on every person, on penicillin and on
every person’s clinical picture, there are other
inefficient antibiotics, but on a lower rate. People had a
certain clinical picture, a kind of specificity in disease
initiated by Staphylococcus aureus. This is the reason
why  some  antibiotics  appear  in  both  groups,  as
efficient and inefficient, but of course, on a lower rate.
DISCUSSIONS
Infections caused by methicillin-resistant strains
may be more difficult to manage or more expensive to
treat, because vancomycin is inherently less
efficacious. The increasing prevalence of MRSA will
inevitably increase vancomycin use, adding further to
the problem of antibiotic-resistant gram-positive
bacteria [8].
Antimicrobial resistance to penicillin, methicillin,
or vancomycin is an unavoidable consequence of the
selective pressure of antibiotic exposure. Although the
details of the epidemiology of staphylococcal drug
resistance may change, the fundamental forces driving
it are similar. The question is not whether resistance
will occur, but how prevalent resistance will become.
Minimizing the antibiotic pressure that favors the
selection of resistant strains is essential to controlling
the emergence of these strains in the hospital and the
community, regardless of their origins [17].
Resistance to these antibiotics has also led to the
use of new, broad-spectrum anti-Gram positive
antibiotics such as linezolid because of its availability
as an oral drug [4].
Vancomycin-resistant S. aureus (VRSA) is a strain
of S. aureus that has become resistant to the
glycopeptides. The first case of vancomycin-
intermediate S. aureus (VISA) was reported in Japan in
1996 [13]; but the first case of S. aureus truly resistant
to glycopeptide antibiotics was only reported in 2002
[6]. Three cases of VRSA infection have been reported
in the United States as of 2005[14].
The treatment of choice for S. aureus infection is
penicillin; but in most countries, penicillin-resistance is
extremely common and first-line therapy is most
commonly a penicillinase-resistant penicillin (for
example, oxacilin or flucloxacillin). Combination
therapy with gentamicin may be used to treat serious
infections like endocarditis, but its use is controversial
because of the high risk of damage to the kidneys. The
duration of treatment depends on the site of infection
and on severity [2].
Antibiotic resistance in S. aureus was almost
unknown when penicillin was first introduced in 1943
observed the antibacterial activity of the penicillium
mould was growing a culture of S. aureus. By 1950,
40% of hospital S. aureus isolates were penicillin
resistant; and by 1960, this had risen to 80% [5].
Patients with affections determined by
Staphylococcus aureus and which are under standard
therapy with antistaphylococcal penicillin or
vancomycin, were administred initial low dose
gentamicin, in order to increase the treatment`s
efficiency. By studying the the administration of a
standard dose of gentamicin as a part of therapy for
Staphylococcus aureus bacteremia, but also for native
valve infective endocarditis, is proven that it is
nephrotoxic and should not be used routinely [9,12].Analele UniversităĠii din Oradea, Fascicula Biologie                                                                                                                                              Tom. XVI / 2, 2009, pp. 70-73
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Testing the sensitivity of Staphylococcus aureus, on
different kind of antibiotics, is very important as
concerning the clinical picture of the disease generated
by this pathogen agent. With the help of these tests, we
had in view to ameliorate the health estate, especially
for the doctors to recommend the most efficient
treatment in case of this disease.
Tested antibiotics of Staphylococcus aureus show
that the most efficient antibiotic is oxacilin (76,66%),
followed by rifampicin and ciprofloxacin.
Other efficient antibiotics in the treatment of
Staphylococcus aureus are eritromycin and linezolid.
The most efficient antibiotic in the treatment of
disease caused by Staphylococcus aureus has proved to
be the penicillin (63.33%).
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